104 related articles for article (PubMed ID: 28993997)
1. Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study.
Terada M; Kinoshita T; Kaito A; Sugita S; Watanabe M; Hayashi R
Surg Today; 2018 Mar; 48(3):325-332. PubMed ID: 28993997
[TBL] [Abstract][Full Text] [Related]
2. Is surgery alone sufficient for treating T1 gastric cancer with extensive lymph node metastases?
Yura M; Yoshikawa T; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
Gastric Cancer; 2020 Mar; 23(2):349-355. PubMed ID: 31512081
[TBL] [Abstract][Full Text] [Related]
3. Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer.
Wang YF; Yin X; Fang TY; Wang YM; Zhang DX; Zhang Y; Wang XB; Wang H; Xue YW
World J Gastrointest Surg; 2022 Feb; 14(2):143-160. PubMed ID: 35317546
[TBL] [Abstract][Full Text] [Related]
4. Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy.
Imamura T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
J Surg Oncol; 2015 Feb; 111(2):221-5. PubMed ID: 25327711
[TBL] [Abstract][Full Text] [Related]
5. Exploratory Analysis to Find Unfavorable Subset of Stage II Gastric Cancer for Which Surgery Alone Is the Standard Treatment; Another Target for Adjuvant Chemotherapy.
Aoyama T; Yoshikawa T; Fujikawa H; Hayashi T; Ogata T; Cho H; Yamada T; Hasegawa S; Tsuchida K; Yukawa N; Oshima T; Rino Y; Masuda M
Int Surg; 2014; 99(6):835-41. PubMed ID: 25437596
[TBL] [Abstract][Full Text] [Related]
6. Oncological outcomes in patients with pT1N0-3 or pT2-3N0 gastric cancer after curative resection without adjuvant chemotherapy.
Yagi S; Nunobe S; Makuuchi R; Ida S; Kumagai K; Ohashi M; Sano T
Langenbecks Arch Surg; 2021 Mar; 406(2):419-426. PubMed ID: 33515064
[TBL] [Abstract][Full Text] [Related]
7. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
[TBL] [Abstract][Full Text] [Related]
8. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
[TBL] [Abstract][Full Text] [Related]
9. Influence of perineural invasion in predicting overall survival and disease-free survival in patients With locally advanced gastric cancer.
Aurello P; Berardi G; Tierno SM; Rampioni Vinciguerra GL; Socciarelli F; Laracca GG; Giulitti D; Pilozzi E; Ramacciato G
Am J Surg; 2017 Apr; 213(4):748-753. PubMed ID: 27613269
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis.
Hanyu T; Matsuki A; Kosugi S; Ishikawa T; Nashimoto A; Yabusaki H; Aizawa M; Ichikawa H; Shimada Y; Hirose Y; Wakai T
Surgery; 2015 Apr; 157(4):716-22. PubMed ID: 25433728
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for gastrectomy in elderly patients with gastric cancer.
Ueno D; Matsumoto H; Kubota H; Higashida M; Akiyama T; Shiotani A; Hirai T
World J Surg Oncol; 2017 Mar; 15(1):59. PubMed ID: 28284210
[TBL] [Abstract][Full Text] [Related]
13. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
[TBL] [Abstract][Full Text] [Related]
15. Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution.
Wu HL; Tian Q; Peng CW; Liu SP; Li Y
Asian Pac J Cancer Prev; 2011; 12(12):3341-5. PubMed ID: 22471477
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for recurrence in T2N0 and T3N0 gastric cancer patients.
Saito H; Murakami Y; Miyatani K; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ikeguchi M
Langenbecks Arch Surg; 2016 Sep; 401(6):823-8. PubMed ID: 27460840
[TBL] [Abstract][Full Text] [Related]
17. Conversion surgery for gastric cancer: A cohort study from a western center.
Morgagni P; Solaini L; Framarini M; Vittimberga G; Gardini A; Tringali D; Valgiusti M; Monti M; Ercolani G
Int J Surg; 2018 May; 53():360-365. PubMed ID: 29654967
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
19. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
